Ivanenkov YA - Search Results

1

Synthesis, biological evaluation and in silico modeling of novel pan-genotypic NS5A inhibitors.

Ivashchenko AA, Ivanenkov YA, Aladinskiy VA, Karapetian RN, Koryakova AG, Ryakhovskiy AA, Mitkin OD, Kravchenko DV, Savchuk NP, Zagribelnyy BA, Ivashchenko AV. Ivashchenko AA, et al. Among authors: ivanenkov ya. Bioorg Med Chem. 2020 Oct 15;28(20):115716. doi: 10.1016/j.bmc.2020.115716. Epub 2020 Aug 20. Bioorg Med Chem. 2020. PMID: 33069072

2

Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.

Korolev D, Balakin KV, Nikolsky Y, Kirillov E, Ivanenkov YA, Savchuk NP, Ivashchenko AA, Nikolskaya T. Korolev D, et al. Among authors: ivanenkov ya. J Med Chem. 2003 Aug 14;46(17):3631-43. doi: 10.1021/jm030102a. J Med Chem. 2003. PMID: 12904067

3

In silico estimation of DMSO solubility of organic compounds for bioscreening.

Balakin KV, Ivanenkov YA, Skorenko AV, Nikolsky YV, Savchuk NP, Ivashchenko AA. Balakin KV, et al. Among authors: ivanenkov ya. J Biomol Screen. 2004 Feb;9(1):22-31. doi: 10.1177/1087057103260006. J Biomol Screen. 2004. PMID: 15006145

4

Kohonen maps for prediction of binding to human cytochrome P450 3A4.

Balakin KV, Ekins S, Bugrim A, Ivanenkov YA, Korolev D, Nikolsky YV, Skorenko AV, Ivashchenko AA, Savchuk NP, Nikolskaya T. Balakin KV, et al. Among authors: ivanenkov ya. Drug Metab Dispos. 2004 Oct;32(10):1183-9. doi: 10.1124/dmd.104.000356. Epub 2004 Jul 1. Drug Metab Dispos. 2004. PMID: 15231683

5

Quantitative structure-metabolism relationship modeling of metabolic N-dealkylation reaction rates.

Balakin KV, Ekins S, Bugrim A, Ivanenkov YA, Korolev D, Nikolsky YV, Ivashchenko AA, Savchuk NP, Nikolskaya T. Balakin KV, et al. Among authors: ivanenkov ya. Drug Metab Dispos. 2004 Oct;32(10):1111-20. doi: 10.1124/dmd.104.000364. Epub 2004 Jul 21. Drug Metab Dispos. 2004. PMID: 15269187

6

Comprehensive computational assessment of ADME properties using mapping techniques.

Balakin KV, Ivanenkov YA, Savchuk NP, Ivashchenko AA, Ekins S. Balakin KV, et al. Among authors: ivanenkov ya. Curr Drug Discov Technol. 2005 Jun;2(2):99-113. doi: 10.2174/1570163054064666. Curr Drug Discov Technol. 2005. PMID: 16472234

7

Efficient optimization strategy for marginal hits active against abl tyrosine kinases.

Tkachenko SE, Okun I, Balakin KV, Petersen CE, Ivanenkov YA, Savchuk NP, Ivashchenko AA. Tkachenko SE, et al. Among authors: ivanenkov ya. Curr Drug Discov Technol. 2004 Oct;1(3):201-10. doi: 10.2174/1570163043335018. Curr Drug Discov Technol. 2004. PMID: 16472247

8

Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitors.

Koryakova AG, Ivanenkov YA, Ryzhova EA, Bulanova EA, Karapetian RN, Mikitas OV, Katrukha EA, Kazey VI, Okun I, Kravchenko DV, Lavrovsky YV, Korzinov OM, Ivachtchenko AV. Koryakova AG, et al. Among authors: ivanenkov ya. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3661-6. doi: 10.1016/j.bmcl.2007.11.121. Epub 2007 Dec 5. Bioorg Med Chem Lett. 2008. PMID: 18502121

9

Compound library design for target families.

Balakin KV, Ivanenkov YA, Savchuk NP. Balakin KV, et al. Among authors: ivanenkov ya. Methods Mol Biol. 2009;575:21-46. doi: 10.1007/978-1-60761-274-2_2. Methods Mol Biol. 2009. PMID: 19727610 Review.

10

A novel influenza virus neuraminidase inhibitor AV5027.

Ivachtchenko AV, Ivanenkov YA, Mitkin OD, Yamanushkin PM, Bichko VV, Leneva IA, Borisova OV. Ivachtchenko AV, et al. Among authors: ivanenkov ya. Antiviral Res. 2013 Dec;100(3):698-708. doi: 10.1016/j.antiviral.2013.10.008. Antiviral Res. 2013. PMID: 24416774

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page